Catalase Modulates the Radio-Sensitization of Pancreatic Cancer Cells by Pharmacological Ascorbate

Pancreatic cancer cells (PDACs) are more susceptible to an oxidative insult than normal cells, resulting in greater cytotoxicity upon exposure to agents that increase pro-oxidant levels. Pharmacological ascorbate (P-AscH<sup>−</sup>), i.e., large amounts given intravenously (IV), generat...

Full description

Bibliographic Details
Main Authors: Juan Du, Rory S. Carroll, Garett J. Steers, Brett A. Wagner, Brianne R. O’Leary, Chris S. Jensen, Garry R. Buettner, Joseph J. Cullen
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/10/4/614
_version_ 1797537454365868032
author Juan Du
Rory S. Carroll
Garett J. Steers
Brett A. Wagner
Brianne R. O’Leary
Chris S. Jensen
Garry R. Buettner
Joseph J. Cullen
author_facet Juan Du
Rory S. Carroll
Garett J. Steers
Brett A. Wagner
Brianne R. O’Leary
Chris S. Jensen
Garry R. Buettner
Joseph J. Cullen
author_sort Juan Du
collection DOAJ
description Pancreatic cancer cells (PDACs) are more susceptible to an oxidative insult than normal cells, resulting in greater cytotoxicity upon exposure to agents that increase pro-oxidant levels. Pharmacological ascorbate (P-AscH<sup>−</sup>), i.e., large amounts given intravenously (IV), generates significant fluxes of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), resulting in the killing of PDACs but not normal cells. Recent studies have demonstrated that P-AscH<sup>−</sup> radio-sensitizes PDAC but is a radioprotector to normal cells and tissues. Several mechanisms have been hypothesized to explain the dual roles of P-AscH<sup>−</sup> in radiation-induced toxicity including the activation of nuclear factor-erythroid 2-related factor 2 (Nrf2), RelB, as well as changes in bioenergetic profiles. We have found that P-AscH<sup>−</sup> in conjunction with radiation increases Nrf2 in both cancer cells and normal cells. Although P-AscH<sup>−</sup> with radiation decreases RelB in cancer cells vs. normal cells, the knockout of RelB does not radio-sensitize PDACs. Cellular bioenergetic profiles demonstrate that P-AscH<sup>−</sup> with radiation increases the ATP demand/production rate (glycolytic and oxidative phosphorylation) in both PDACs and normal cells. Knocking out catalase results in P-AscH<sup>−</sup> radio-sensitization in PDACs. In a phase I trial where P-AscH<sup>−</sup> was included as an adjuvant to the standard of care, short-term survivors had higher catalase levels in tumor tissue, compared to long-term survivors. These data suggest that P-AscH<sup>−</sup> radio-sensitizes PDACs through increased peroxide flux. Catalase levels could be a possible indicator for how tumors will respond to P-AscH<sup>−</sup>.
first_indexed 2024-03-10T12:15:21Z
format Article
id doaj.art-5d368059696c4251aebd2719099c0cd8
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-10T12:15:21Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-5d368059696c4251aebd2719099c0cd82023-11-21T15:52:24ZengMDPI AGAntioxidants2076-39212021-04-0110461410.3390/antiox10040614Catalase Modulates the Radio-Sensitization of Pancreatic Cancer Cells by Pharmacological AscorbateJuan Du0Rory S. Carroll1Garett J. Steers2Brett A. Wagner3Brianne R. O’Leary4Chris S. Jensen5Garry R. Buettner6Joseph J. Cullen7Free Radical and Radiation Biology Program, Department of Radiation Oncology, The University of Iowa Carver College of Medicine, Iowa City, IA 52242, USAFree Radical and Radiation Biology Program, Department of Radiation Oncology, The University of Iowa Carver College of Medicine, Iowa City, IA 52242, USAFree Radical and Radiation Biology Program, Department of Radiation Oncology, The University of Iowa Carver College of Medicine, Iowa City, IA 52242, USADepartment of Surgery, The University of Iowa Carver College of Medicine, Iowa City, IA 52242, USAFree Radical and Radiation Biology Program, Department of Radiation Oncology, The University of Iowa Carver College of Medicine, Iowa City, IA 52242, USADepartment of Pathology, The University of Iowa Carver College of Medicine, Iowa City, IA 52242, USADepartment of Surgery, The University of Iowa Carver College of Medicine, Iowa City, IA 52242, USAFree Radical and Radiation Biology Program, Department of Radiation Oncology, The University of Iowa Carver College of Medicine, Iowa City, IA 52242, USAPancreatic cancer cells (PDACs) are more susceptible to an oxidative insult than normal cells, resulting in greater cytotoxicity upon exposure to agents that increase pro-oxidant levels. Pharmacological ascorbate (P-AscH<sup>−</sup>), i.e., large amounts given intravenously (IV), generates significant fluxes of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), resulting in the killing of PDACs but not normal cells. Recent studies have demonstrated that P-AscH<sup>−</sup> radio-sensitizes PDAC but is a radioprotector to normal cells and tissues. Several mechanisms have been hypothesized to explain the dual roles of P-AscH<sup>−</sup> in radiation-induced toxicity including the activation of nuclear factor-erythroid 2-related factor 2 (Nrf2), RelB, as well as changes in bioenergetic profiles. We have found that P-AscH<sup>−</sup> in conjunction with radiation increases Nrf2 in both cancer cells and normal cells. Although P-AscH<sup>−</sup> with radiation decreases RelB in cancer cells vs. normal cells, the knockout of RelB does not radio-sensitize PDACs. Cellular bioenergetic profiles demonstrate that P-AscH<sup>−</sup> with radiation increases the ATP demand/production rate (glycolytic and oxidative phosphorylation) in both PDACs and normal cells. Knocking out catalase results in P-AscH<sup>−</sup> radio-sensitization in PDACs. In a phase I trial where P-AscH<sup>−</sup> was included as an adjuvant to the standard of care, short-term survivors had higher catalase levels in tumor tissue, compared to long-term survivors. These data suggest that P-AscH<sup>−</sup> radio-sensitizes PDACs through increased peroxide flux. Catalase levels could be a possible indicator for how tumors will respond to P-AscH<sup>−</sup>.https://www.mdpi.com/2076-3921/10/4/614pharmacological ascorbateDNA damageDNA repairpancreatic cancervitamin C
spellingShingle Juan Du
Rory S. Carroll
Garett J. Steers
Brett A. Wagner
Brianne R. O’Leary
Chris S. Jensen
Garry R. Buettner
Joseph J. Cullen
Catalase Modulates the Radio-Sensitization of Pancreatic Cancer Cells by Pharmacological Ascorbate
Antioxidants
pharmacological ascorbate
DNA damage
DNA repair
pancreatic cancer
vitamin C
title Catalase Modulates the Radio-Sensitization of Pancreatic Cancer Cells by Pharmacological Ascorbate
title_full Catalase Modulates the Radio-Sensitization of Pancreatic Cancer Cells by Pharmacological Ascorbate
title_fullStr Catalase Modulates the Radio-Sensitization of Pancreatic Cancer Cells by Pharmacological Ascorbate
title_full_unstemmed Catalase Modulates the Radio-Sensitization of Pancreatic Cancer Cells by Pharmacological Ascorbate
title_short Catalase Modulates the Radio-Sensitization of Pancreatic Cancer Cells by Pharmacological Ascorbate
title_sort catalase modulates the radio sensitization of pancreatic cancer cells by pharmacological ascorbate
topic pharmacological ascorbate
DNA damage
DNA repair
pancreatic cancer
vitamin C
url https://www.mdpi.com/2076-3921/10/4/614
work_keys_str_mv AT juandu catalasemodulatestheradiosensitizationofpancreaticcancercellsbypharmacologicalascorbate
AT roryscarroll catalasemodulatestheradiosensitizationofpancreaticcancercellsbypharmacologicalascorbate
AT garettjsteers catalasemodulatestheradiosensitizationofpancreaticcancercellsbypharmacologicalascorbate
AT brettawagner catalasemodulatestheradiosensitizationofpancreaticcancercellsbypharmacologicalascorbate
AT brianneroleary catalasemodulatestheradiosensitizationofpancreaticcancercellsbypharmacologicalascorbate
AT chrissjensen catalasemodulatestheradiosensitizationofpancreaticcancercellsbypharmacologicalascorbate
AT garryrbuettner catalasemodulatestheradiosensitizationofpancreaticcancercellsbypharmacologicalascorbate
AT josephjcullen catalasemodulatestheradiosensitizationofpancreaticcancercellsbypharmacologicalascorbate